Iron deficiency in pulmonary arterial smooth muscle cells induces pulmonary arterial hypertension through endothelin-1

Iron deficiency in pulmonary arterial smooth muscle cells induces pulmonary arterial hypertension through endothelin-1

Dades bibliogràfiques
Autors principals:	Lakhal-Littleton, S, Crosby, A, Mohammad, G, Frise, M, Carr, C, Loick, P, Robbins, P
Format:	Conference item
Idioma:	English
Publicat:	BMJ Publishing Group 2019

Ítems similars

Intracellular iron deficiency in pulmonary arterial smooth muscle cells induces pulmonary arterial hypertension in mice
per: Lakhal-Littleton, S, et al.
Publicat: (2019)

Iron, oxygen, and the pulmonary circulation.
per: Frise, M, et al.
Publicat: (2015)

Electrophysiologically distinct smooth muscle cell subtypes in rat conduit and resistance pulmonary arteries.
per: Smirnov, S, et al.
Publicat: (2002)

Atrial septostomy in the treatment of severe pulmonary arterial hypertension.
per: McCann, F, et al.
Publicat: (2004)

Pulmonary arterial hypertension : diagnosis and evidence-based treatment /
per: Barst, Robyn
Publicat: (2008)

The increase in pulmonary arterial pressure caused by hypoxia depends on iron status.
per: Smith, T, et al.
Publicat: (2008)

Ion channels as convergence points in the pathology of pulmonary arterial hypertension
per: Jouen-Tachoire, TRH, et al.
Publicat: (2021)

Intravenous iron and pulmonary hypertension in intensive care
per: Smith, T, et al.
Publicat: (2011)

Intravenous iron and pulmonary hypertension in intensive care.
per: Smith, T, et al.
Publicat: (2011)

Cost-utility of ambrisentan and bosentan for pediatric pulmonary arterial hypertension
per: Buendia, JA, et al.
Publicat: (2023)

Intravenous iron delivers a sustained (8-week) lowering of pulmonary artery pressure during exercise in healthy older humans
per: Cheng, H, et al.
Publicat: (2019)

Atrial septostomy in the treatment of severe pulmonary arterial hypertension [3] (multiple letters)
per: McCann, F, et al.
Publicat: (2004)

Maternal Pulmonary Arterial Hypertension in Pregnancy: Incidence, Risk Factors, Management and Outcomes
per: Mistry, V, et al.
Publicat: (2014)

TMEM16A/anoctamin 1 protein mediates calcium-activated chloride currents in pulmonary arterial smooth muscle cells.
per: Manoury, B, et al.
Publicat: (2010)

A therapeutic antibody targeting osteoprotegerin attenuates severe experimental pulmonary arterial hypertension
per: Arnold, ND, et al.
Publicat: (2019)

Rare unicuspid pulmonary valve and pulmonary artery aneurysm in an elderly asymptomatic patient
per: Burrage, MK, et al.
Publicat: (2020)

Embolization of a bronchial artery – pulmonary artery arterio – venous malformation
per: Pua, Uei, et al.
Publicat: (2020)

Telemetric adjustable pulmonary artery banding for pulmonary hypertension in infants with congenital heart defects: Interventional procedures guidance [IPG505]
per: Powell, J, et al.
Publicat: (2014)

Frataxin deficiency promotes endothelial senescence in pulmonary hypertension
Publicat: (2024)

Case report: the 'vanished' left pulmonary artery
per: Chan, Charmaine Jiahui, et al.
Publicat: (2024)

Pulmonary arterial hypertension with abnormal V/Q single-photon emission computed tomography
per: Chan, K, et al.
Publicat: (2017)

Structural consequences of BMPR2 kinase domain mutations causing pulmonary arterial hypertension
per: Chaikuad, A, et al.
Publicat: (2019)

Release by hypoxia of a soluble vasoconstrictor from rabbit small pulmonary arteries.
per: Talbot, N, et al.
Publicat: (2003)

Pulmonary artery catheterization and mortality in critically ill patients.
per: Padkin, A, et al.
Publicat: (2001)

Species−specific pulmonary arterial asymmetry determines species differences in regional pulmonary perfusion
per: Tawhai, M
Publicat: (2009)

Species-specific pulmonary arterial asymmetry determines species differences in regional pulmonary perfusion.
per: Burrowes, K, et al.
Publicat: (2009)

Can intravenous endothelin-1 be used to enhance hypoxic pulmonary vasoconstriction in healthy humans?
per: Talbot, N, et al.
Publicat: (2008)

Plasma metabolomics implicates modified transfer RNAs and altered bioenergetics in the outcomes of pulmonary arterial hypertension
per: Rhodes, CJ, et al.
Publicat: (2016)

Commercial air travel and in-flight pulmonary hypertension.
per: Smith, T, et al.
Publicat: (2013)

Grossly abnormal ventilation/perfusion SPECT study in idiopathic pulmonary arterial hypertension without thromboembolism
per: Chan, K, et al.
Publicat: (2018)

Primary Pulmonary Hypertension
per: Abdul Rani, Mohammed Fauzi
Publicat: (2000)

Hydralazine in pulmonary hypertension.
per: Rozkovec, A, et al.
Publicat: (1982)

Pulmonary artery pressure increases during commercial air travel in healthy passengers.
per: Smith, T, et al.
Publicat: (2012)

Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis
per: Rhodes, CJ, et al.
Publicat: (2018)

Tetrahydrobiopterin deficiency causes pulmonary hypertension: Effects on lung superoxide levels, hypoxic pulmonary vasoconstriction and vascular remodelling
per: Khoo, J, et al.
Publicat: (2004)

Iron deficiency and supplementation in heart failure
per: Lakhal-Littleton, S, et al.
Publicat: (2024)

Effects of iron supplementation and depletion on hypoxic pulmonary hypertension: two randomized controlled trials.
per: Smith, T, et al.
Publicat: (2009)

GTP cyclohydrolase I deficiency results in oxidative stress and pulmonary hypertension
per: Khoo, J, et al.
Publicat: (2004)

Tetrahydrobiopterin deficiency uncouples nitric oxide synthase and causes pulmonary hypertension
per: Khoo, J, et al.
Publicat: (2004)

Two-conduit repair for anomalous origin of the left coronary artery from the pulmonary artery in an adult.
per: Kattach, H, et al.
Publicat: (2004)